Company Filing History:
Years Active: 2017-2019
Title: **The Innovations of Sharon Moulis: Pioneering Cancer Treatment**
Introduction
Sharon Moulis is an accomplished inventor located in Manchester, NH, who has made significant contributions to the field of cancer therapy. With a total of two patents to her name, Moulis is known for her innovative methodologies that enhance treatment effectiveness for patients suffering from non-hematological cancers, particularly gynecological cancers.
Latest Patents
Moulis's latest patents focus on biomarker profiles that predict outcomes of cancer therapy utilizing ERBB3 inhibitors and chemotherapies. These patents provide methods for optimizing therapy and aiding in the selection of patients who will benefit from specific cancer treatments. One of the pivotal aspects of her work is to determine whether patients will benefit from treatments such as ErbB3 inhibitors, which may include anti-ErbB3 antibodies, taxanes, or aromatase inhibitors. By analyzing levels of particular biomarkers and their combinations in biological samples from patients, Moulis’s methods enable healthcare providers to personalize treatment plans. The biological samples often include sections of biopsies, such as formalin-fixed paraffin-embedded specimens, and the biomarkers investigated may comprise proteins and nucleic acids that play critical roles in ErbB-mediated signal transduction.
Career Highlights
Throughout her career, Sharon Moulis has been dedicated to advancing medical science and improving patient outcomes through her inventive approaches. Her work is highly regarded within the biomedical community, especially for its potential to transform standard cancer therapies into more targeted and effective treatments.
Collaborations
In her role at Merrimack Pharmaceuticals, Inc., Moulis collaborates with other skilled professionals, including colleagues like Bambang Adiwijaya and Akos Czibere. These collaborations foster an environment of innovation and research that amplifies their collective impact on cancer treatment advancements.
Conclusion
Sharon Moulis stands out as a notable inventor in the medical field, with her patents showcasing innovative solutions for improving cancer therapy. Her dedication to researching biomarker profiles enhances the landscape of personalized medicine, promising better outcomes for patients battling cancer.